We are deeply saddened by the sudden passing of Andrew McKee, former President and CEO of JDRF Canada. Andrew began his journey with JDRF Canada as a Board member. His passion and dedication led him to assume the role of President and CEO for several years. Through his leadership, he blazed an exciting trail for […]
Ontario announces coverage for continuous glucose monitoring systems under the Assistive Devices Program
Friday, March 4, 2022 Toronto, ON – Today, the Ontario government made an exciting announcement that will provide better access for Ontarians with type 1 diabetes (T1D) to continuous glucose monitoring (CGM) systems. These devices will be covered under Ontario’s Assistive Devices Program (ADP), which also provides coverage for insulin pumps. ADP is available to […]
Helping the diabetes community in Ukraine
Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
JDRF in the United States joining partners to support new affordable insulin project with a focus on the US market.
March 3, 2022 – Statement by Dave Prowten, President and CEO, JDRF Canada JDRF has long supported both public and private sector initiatives to make insulin more affordable to ensure people with type 1 diabetes (T1D) can access the insulin they need to stay alive and healthy until we have cures. Today, just two days […]
Alberta announces new coverage for continuous glucose monitoring (CGM) systems
Wednesday February 2, 2022 – JDRF Canada is excited to share that the Alberta government has announced that they will provide public coverage for continuous glucose monitoring (CGM) systems for people with type 1 diabetes (T1D) who are under the age of 18. To qualify, individuals must be enrolled in the province’s non-group coverage or […]
JDRF Canada’s First Centre of Excellence in Type 1 Diabetes Research Launches at the University of British Columbia
Toronto, ON — December 8, 2021 – JDRF Canada, the largest Canadian charitable funder of type 1 diabetes (T1D) research, and the UBC Faculty of Medicine are proud to announce the establishment of Canada’s first JDRF Centre of Excellence in T1D research at the University of British Columbia. Exclusively focused on research to cure T1D, the Centre is a key pillar of JDRF Canada’s $100M Campaign to Accelerate that launched earlier […]
JDRF and CIHR Announce Recipients of New Grants to Accelerate Type 1 Diabetes Research
To mark November’s National Diabetes Awareness Month, JDRF is excited to announce a new investment of $7 million to support four Canadian research teams as part of the JDRF-CIHR Partnership to Defeat Diabetes. These grants will help to accelerate development of stem cell-based therapies for type 1 diabetes (T1D), improve pediatric diabetes research across Canada, […]
JDRF Canada and Canada’s Stem Cell Network partner to launch National Fellowship Program in Type 1 Diabetes
November 15, 2021 (Ottawa/Toronto) JDRF Canada and Canada’s Stem Cell Network are pleased to announce the JDRF-SCN National Fellowship Program in Type 1 Diabetes, a new opportunity for high-calibre postdocs from across Canada with expertise in stem cells, regenerative medicine, immunology or related fields to join the JDRF Centre of Excellence at the University of British Columbia (UBC) to pursue research focused on treating and curing type […]
JDRF Canada marks National Diabetes Awareness Month by launching new Monster Tamer Campaign
Toronto, ON — November 10, 2021 – JDRF Canada, the leading organization funding type 1 diabetes (T1D) research, is marking November and National Diabetes Awareness Month (NDAM) with a new Monster Tamer Campaign. T1D is an autoimmune disease that many have said can feel like living with a monster – a monster that requires you to […]
JDRF and Sun Life challenge corporate Canada to move work aside and move for a cure
The Sun Life Ride to Defeat Diabetes for JDRF invites people across Canada to raise funds to support type 1 diabetes research TORONTO, Oct 5, 2021 – One of Canada’s top fundraising events will be taking place on October 7, 2021. For the second straight year, the Sun Life Ride to Defeat Diabetes for JDRF […]
Filling the Forgotten Gaps in Care – JDRF Canada Launches Strategy for Mental Health and Type 1 Diabetes
TORONTO, September 28, 2021 — 2021 marks the 100th anniversary of the discovery of insulin in Toronto. Earlier this year, in honour of this anniversary, JDRF Canada, the largest charitable funder of type 1 diabetes (T1D) research in Canada, launched its $100M Campaign to Accelerate to build upon a long legacy of outstanding Canadian diabetes research, accelerating towards cures […]
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
Health Canada has recalled a single lot of Eli Lilly Glucagon, as it may be contaminated. The lot number is D239382A, expiry May 10, 2022. Please check your glucagon kits and return it to the pharmacy if you have a vial with this lot number. All other lot numbers are fine. For more information, click here: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76507a-eng.php.